Chelation therapy for peripheral arterial occlusive disease: A systematic review

Circulation

Volumn 96, Issue 3, 1997, Pages 1031-1033

  Ernst, E ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

Arteriosclerosis; Chelation therapy; Peripheral vascular disease

Indexed keywords

BICARBONATE; CHELATING AGENT; EDETATE SODIUM; EDETIC ACID; HEPARIN; IRON; LEAD; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE; TRACE ELEMENT; VITAMIN;

ALTERNATIVE MEDICINE; ANGINA PECTORIS; BLOOD PRESSURE; CHELATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; DOUBLE BLIND PROCEDURE; HUMAN; HYPOCALCEMIA; INTERMITTENT CLAUDICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INJURY; LEAD POISONING; MALE; META ANALYSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE BLIND PROCEDURE;

EID: 0030857522     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.3.1031     Document Type: Review

References (36)

1. Brecher H, Brecher A. Forty something forever: a consumer's guide to chelation therapy and other heart savers. Health Conscious. 1994;15:35-38.
2. Dingle DL. Chelation for osteoporosis. Dig Chiropractic Econ. 1986;29:74.
3. Blumer W, Cranton EM. Ninety percent reduction in cancer mortality after chelation therapy with EDTA. J Adv Med. 1989;2:183-187.
4. Olszewer E, Carter JC. EDTA chelation therapy in chronic degenerative disease. Med Hypotheses. 1988;27:41-49.
5. Olszewer E, Carter JP. EDTA chelation therapy: a retrospective study of 2,870 patients. J Adv Med. 1989;2:197-211.
6. Laquasto MJ. How is their circulation? Oral chelation. Am Chiropractor. 1985:248.
7. Godfrey ME. EDTA chelation as a treatment of arteriosclerosis. N Z Med J. 1990;103:162-163.
8. Casadorph RH, Farr CH. EDTA chelation therapy, III: treatment of peripheral arterial occlusion, an alternative to amputation. J Hol Med. 1983;5:3-15.
9. Clarke NE, Clarke CN, Mosher RE. The 'in-vivo' dissolution of metastatic calcium: an approach to atherosclerosis. Am J Med Sci. 1955;229:142-149.
10. Boyle AJ, Jasper JJ, McCormic H. Clinic and therapy: studies in human and induced atherosclerosis employing ethylene diamine tetraacetic acid. Bull Schweiz Akad Med Wiss. 1957;13:408-425.
11. Casdorph HR. EDTA chelation therapy: efficacy in atherosclerotic heart disease. J Hol Med. 1981;3:53-58.
12. Clarke NE Sr, Clarke NE Jr, Mosher RE. Treatment of occlusive vascular disease with disodium ethylene diamine tetraacetic acid (EDTA). Am J Med Sci. 1960;239:732-744.
13. Kitchell JR, Palmon F, Aytan N, Meltzer L. The treatment of coronary artery disease with disodium EDTA. Am J Cardiol. 1963;11:501-506.
14. Lamar CP. Chelation therapy of occlusive arteriosclerosis in diabetic patients. Angiology. 1964;15:379-395.
15. Lamar CP. Chelation endarterectomy for occlusive atherosclerosis. J Am Geriatr Soc. 1966;14:272-294.
16. Nissel H. Arteriosklerose und Chelattherapie. Wien Med Wochenschr. 1986;136:586-588.
17. Wirebaugh SR, Geraets DR. Apparent failure of coronary arteriosclerosis. DICP. 1990;24:22-25.
18. Scott PJ. Chelation therapy: evolution or devolution of a nostrum? N Z Med J. 1988;101:109-110.
19. Scott PJ. Chelation therapy for degenerative vascular disease. N Z Med J. 1982;95:538-539.
20. Robinson D. Chelation therapy. N Z Med J. 1982;95:750. Letter.
21. Softer A. Chelation clinics: an abuse of the physician's freedom of choice. Arch Intern Med. 1984;144:1741-1742.
22. Lyons RD. Chelation: miracle cure or false hope? Med J Aust. 1985;142:519-520.
23. Thompson LJ. Chelation therapy. N Z Med J. 1990;103:326-327.
24. Patterson R. Chelation therapy and Uncle John. Can Med Assoc J. 1989;140:829-831.
25. EDTA chelation: a rebuttal. J Adv Med. 1992;5:3-5.
26. Olszewer E, Sabbag FC, Carter JA. A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease. J Natl Med Assoc. 1990;82:173-177.
27. Guldager B, Jelnes R, Jørgensen SJ, Nielsen JS, Klærke A, Morgensen K, Larsen KE, Reimer E, Holm J, Ottesen S. EDTA treatment of intermittent claudication: a double-blind, placebo-controlled study. J Intern Med. 1992;231:261-267.
28. Sloth-Nielsen J, Guldager B, Mouitzen C, Lund EB, Egeblad M, Nørregaard O, Jørgenson SL, Jelnes R. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis. Am J Surg. 1991;162:122-125.
29. van Rij AM, Solomon C, Packer SGK, Hopkins WG. Chelation therapy for intermittent claudication. Circulation. 1994;90:1194-1199.
30. Diagnostic and therapeutic technology assessment: chelation therapy. JAMA. 1983;250:672.
31. Rathmann KL, Golightly LK. Chelation therapy of atherosclerosis. Drug Intell Clin Pharm. 1984;18:1000-1003.
32. Perry W. Chelation therapy. Compl Ther Med. 1994;2:17-18.
33. Rinse J. Arteriosclerosis, a plurideficiency disease. Am Chiropractor. 1987;Jan:16-28.
34. Born GR, Geurkink TL. Improved peripheral vascular function with low dose intravenous EDTA. Townsend Lett. 1994;132:722-726.
35. Meltzer LE, Kitchell JR, Palmon FJ. The long term use, side effects, and toxicity of disodium ethyldiamine tetraacetic acid (EDTA). Am J Med Sci. 1961;242:51-57.
36. Schellander F. Overview of chelation therapy. Int J Alt Compl Med. 1992;10:23-24.